VKH

Virtu KCG Holdings Portfolio holdings

AUM $2.24B
1-Year Est. Return 17.11%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+17.11%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.24B
AUM Growth
-$249M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,992
New
Increased
Reduced
Closed

Top Sells

1 +$13.2M
2 +$12.3M
3 +$11.2M
4
META icon
Meta Platforms (Facebook)
META
+$8.59M
5
VTRS icon
Viatris
VTRS
+$7.94M

Sector Composition

1 Consumer Discretionary 9.76%
2 Healthcare 8.71%
3 Technology 8.68%
4 Financials 8.61%
5 Industrials 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBHC
3551
The Brand House Collective
TBHC
$22.7M
-17,285
KMPR icon
3552
Kemper
KMPR
$1.73B
-10,621
KN icon
3553
Knowles
KN
$2.15B
-14,435
KNOP icon
3554
KNOT Offshore Partners
KNOP
$365M
-9,588
KOSS icon
3555
Koss Corp
KOSS
$38.8M
-12,842
KPRX icon
3556
Kiora Pharmaceuticals
KPRX
$8.02M
-6
KRE icon
3557
State Street SPDR S&P Regional Banking ETF
KRE
$3.94B
-29,639
KRNY icon
3558
Kearny Financial
KRNY
$470M
-16,241
KXI icon
3559
iShares Global Consumer Staples ETF
KXI
$1B
-4,126
LADR
3560
Ladder Capital
LADR
$1.29B
-13,014
LAMR icon
3561
Lamar Advertising Co
LAMR
$13.8B
-18,424
LBTYK icon
3562
Liberty Global Class C
LBTYK
$4.09B
-11,883
LDUR icon
3563
PIMCO Enhanced Low Duration Active Exchange-Traded Fund
LDUR
$1.37B
-23,766
LFUS icon
3564
Littelfuse
LFUS
$8.13B
-4,181
LILAK icon
3565
Liberty Latin America Class C
LILAK
$1.55B
-11,643
LKQ icon
3566
LKQ Corp
LKQ
$7.82B
-67,370
LMBS icon
3567
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.01B
-7,728
LOGI icon
3568
Logitech
LOGI
$13.3B
-9,698
LPCN icon
3569
Lipocine
LPCN
$45M
-1,973
LPLA icon
3570
LPL Financial
LPLA
$24.7B
-11,714
LPG icon
3571
Dorian LPG
LPG
$1.48B
-32,485
LQDH icon
3572
iShares Interest Rate Hedged Corporate Bond ETF
LQDH
$493M
-4,299
LSCC icon
3573
Lattice Semiconductor
LSCC
$12.5B
-13,156
LSTA icon
3574
Lisata Therapeutics
LSTA
$44.4M
-2,419
LXRX icon
3575
Lexicon Pharmaceuticals
LXRX
$694M
-14,317